OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate
- Friday, April 8, 2022, 7:06
- Finance
- Add a comment
Identified knockdown of target genes for the NASH treatment candidate Reduction of ALT and AST liver marker levels observed in monkey models Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, South Korea, April 8, 2022 /PRNewswire/ — OliX…
About the Author
adminasapcorp has written 41552 stories on this site.